ArticleTherapeutic advances in medical oncology2026
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study.
Sebastiaan N Siegerink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.